A Pro504 → Ser Substitution in the β-Subunit of β-Hexosaminidase A Inhibits α-Subunit Hydrolysis of GM2Ganglioside, Resulting in Chronic Sandhoff Disease
Open Access
- 1 August 1998
- journal article
- Published by Elsevier
- Vol. 273 (33) , 21386-21392
- https://doi.org/10.1074/jbc.273.33.21386
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Late-onset G sub M2 gangliosidosisNeurology, 1996
- Direct Determination of the Substrate Specificity of the α-Active Site in Heterodimeric β-Hexosaminidase ABiochemistry, 1996
- Specific Recognition of N-Acetylneuraminic Acid in the GM2 Epitope by Human GM2 Activator ProteinPublished by Elsevier ,1995
- Refined Mapping of the GM2 Activator Protein (GM2A) Locus to 5q31.3-q33.1, Distal to the Spinal Muscular Atrophy LocusGenomics, 1993
- Activator proteins and topology of lysosomal sphingolipid catabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage diseaseHuman Genetics, 1992
- The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Assignment of β-hexosaminidase A α-subunit to human chromosomal region 15q23→q24Cytogenetic and Genome Research, 1991
- Xmnl RFLP at 5q13 detected by a 0.49 kb Xmn I fragment of human hexosaminidase (HEXB) cDNANucleic Acids Research, 1988
- Mutation in GM2‐Gangliosidosis B1 VariantJournal of Neurochemistry, 1988